JLABS @ Shanghai
The Future of Innovation is here
Johnson & Johnson has invested significantly in innovation in China for over 35 years. Johnson & Johnson Innovation opened in Shanghai one of its four innovation centers in 2014 and now JLABS is proud to open its doors to support scientific entrepreneurs in Shanghai, China and Asia.
China innovating for the world
New frontiers of science
China is leading the world in artificial intelligence (AI), gene therapy, micro-biome... ...and other new areas of science to solve challenges with benefits that can be shared with the world
Rise of health tech
An emerging convergence of tech and healthcare shows promise of helping the country plug significant gaps in meeting healthcare demand, with companies like Alibaba, PingAn, and TenCent making big moves into healthcare
After the U.S., China now has the largest number of
“unicorns”(1) worldwide (1)privately-held startups valued at >US$1B
Shanghai has embraced the latest technologies such as AI, robotics and cloud-based computing, to become a vital center for advanced technology leadership.
Zhangjiang Hi tech Park* is home to over 600 biotech and pharmaceutical companies and is aiming to create an innovative eco-system with leading research platforms and facilities.
*China’s Silicon Valley
One of the world’s largest R&D spenders
The government spent a total of $279 billion on R&D in 2017... ...with an annual growth rate of 14% and an overall 70.9% increase since 2012
more than $3 billion worth of life sciences deals have been made... ... within the first half of 2017, surpassing the total amount of investment in the whole of 2016
VC investments in China have grown exponentially... ...In Q2 2018, China start-ups accounted for 47% of the world’s venture capital funding. From 2013 to 2018, China saw a 1,287% growth in life science investment